Unleashing a Lazarus Effect With Selpercatinib in a Never-Smoker Patient With Stage IV, Chemo-Immunotherapy Refractory, RET C630Y-Mutant, Small-Cell Lung Cancer: A First Case Report

JCO Precis Oncol. 2023 Sep:7:e2300321. doi: 10.1200/PO.23.00321.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / genetics
  • Proto-Oncogene Proteins c-ret / genetics
  • Pyrazoles
  • Pyridines
  • Small Cell Lung Carcinoma* / drug therapy
  • Small Cell Lung Carcinoma* / genetics
  • Smokers

Substances

  • selpercatinib
  • Pyrazoles
  • Pyridines
  • RET protein, human
  • Proto-Oncogene Proteins c-ret